The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder

BACKGROUND: Intranasal esketamine demonstrates rapid improvement of depressive symptoms. However, transient adverse effects (dissociation, sedation and dizziness) may occur, which could impact driving performance. AIMS: To evaluate the effects of 84 mg intranasal esketamine on driving performance in...

Descripción completa

Detalles Bibliográficos
Autores principales: Dijkstra, Francis M, van de Loo, Aurora JAE, Abdulahad, Smedra, Bosma, Else R, Hartog, Mitch, Huls, Hendrikje, Kuijper, Dianne C, de Vries, Esther, Solanki, Bhavna, Singh, Jaskaran, Aluisio, Leah, Zannikos, Peter, Stuurman, Frederik E, Jacobs, Gabriël E, Verster, Joris C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112620/
https://www.ncbi.nlm.nih.gov/pubmed/35212235
http://dx.doi.org/10.1177/02698811221078764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112620/
https://www.ncbi.nlm.nih.gov/pubmed/35212235
http://dx.doi.org/10.1177/02698811221078764

Ejemplares similares